Page last updated: 2024-08-18

pyrroles and Berger Disease

pyrroles has been researched along with Berger Disease in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gunnarsson, I; Jacobson, SH; Lundahl, J; Lundberg, S1
Ballarín, J; Bestard, O; Carrera, M; Cruzado, JM; Díaz, M; Fulladosa, X; Grinyó, JM; Ibernón, M; Navarro, I; Poveda, R; Romero, R; Torras, J1
Berger, E; Biro, A; Boaz, M; Briliant, A; Fux, A; Katzir, Z; Leibovitch, E; Matas, Z; Schreiber, L; Vaknin, H1
Hashimoto, T; Inayama, Y; Iwatsubo, K; Kihara, M; Kokuho, T; Kuji, T; Oshikawa, J; Tamura, K; Tanaka, K; Toya, Y; Umemura, S; Yabana, M; Yanagi, M; Yoshida, S1

Trials

1 trial(s) available for pyrroles and Berger Disease

ArticleYear
Low-dose sirolimus combined with angiotensin-converting enzyme inhibitor and statin stabilizes renal function and reduces glomerular proliferation in poor prognosis IgA nephropathy.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2011, Volume: 26, Issue:11

    Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Atorvastatin; Blood Pressure; Case-Control Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enalapril; Female; Follow-Up Studies; Glomerular Filtration Rate; Glomerulonephritis, IGA; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Kidney Glomerulus; Male; Middle Aged; Pilot Projects; Prognosis; Prospective Studies; Pyrroles; Sirolimus; Young Adult

2011

Other Studies

3 other study(ies) available for pyrroles and Berger Disease

ArticleYear
Atorvastatin-induced modulation of monocyte respiratory burst in vivo in patients with IgA nephropathy: a chronic inflammatory kidney disease.
    Clinical nephrology, 2010, Volume: 73, Issue:3

    Topics: Adolescent; Adult; Aged; Atorvastatin; Biopsy; Biotransformation; Creatinine; Cytokines; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Follow-Up Studies; Glomerular Filtration Rate; Glomerulonephritis, IGA; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Monocytes; Oxidative Stress; Pyrroles; Respiratory Burst; Treatment Outcome; Young Adult

2010
Effect of atorvastatin on IgA nephropathy in the rat.
    Clinical nephrology, 2013, Volume: 79, Issue:3

    Topics: Animals; Atorvastatin; Creatinine; Fluorescent Antibody Technique; Glomerulonephritis, IGA; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Male; Pyrroles; Rats; Rats, Inbred WKY

2013
Behçet's disease complicated by IgA nephropathy with nephrotic syndrome.
    Clinical and experimental nephrology, 2008, Volume: 12, Issue:3

    Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Atorvastatin; Behcet Syndrome; Benzimidazoles; Biphenyl Compounds; Dilazep; Drug Therapy, Combination; Female; Glomerulonephritis, IGA; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Nephrotic Syndrome; Pyrroles; Tetrazoles; Vasodilator Agents

2008